Assessment of histopathological markers for response to primary systemic therapy
Sato, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 409-413
2012
ISSN/ISBN: 0047-1852 PMID: 23350432 Document Number: 657741
Document emailed within 1 workday
Related Documents
Ross, L.; Stevens, W.; Rabusa, C.; Wilson, M.; Ferdowsi, N.; Walker, J.; Sahhar, J.; Ngian, G.-S.; Zochling, J.; Roddy, J.; Tymms, K.; Major, G.; Strickland, G.; Proudman, S.M.; Nikpour, M. 2018: The role of inflammatory markers in assessment of disease activity in systemic sclerosis Clinical and Experimental Rheumatology 36 Suppl 113(4): 126-134Petrova, O.V.; Shashin, S.A.; Tarasov, D.G. 2015: Markers of Systemic Inflammatory Response in Patients Operated for Complications of Infectious Endocarditis Klinicheskaia Meditsina 93(7): 26-30
Novikov, I.A.; Novikov, A.I.; Repina, T.V.; Radul, E.V.; Romanov, A.A. 2010: Changes in markers of systemic inflammatory response and functional state of the vascular wall in patients with early syphilis Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2010(5): 21-24
Snežana Jovičić; Ignjatovi, S.ć; Dajak, M.; Kangrga, R.; Majki, N.ć-Singh 2009: Association of Lipid and Inflammatory Markers with C-Reactive Protein in Cardiovascular Risk Assessment for Primary Prevention Clinical Laboratory 55(11-12): 411-419
Godoy, D.; Boccio, A.; Hugo, N. 2002: Systemic inflammatory response syndrome and primary of spontaneous intracerebral haemorrhage Revista de Neurologia 35(12): 1101-1105
Rodriguez-Frias, F.; Jardi, R.; Schaper, M.; Buti, M.; Ferrer-Costa, C.; Tabernero, D.; Homs, M.; Esteban, R. 2008: Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response Antiviral Therapy 13(8): 991-999
Hergesell, O.; Andrassy, K.; Nawroth, P. 1996: Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis Thrombosis and Haemostasis 75(6): 892-898
Kreimeier, U.; Peter, K. 1998: Strategies of volume therapy in sepsis and systemic inflammatory response syndrome Kidney International. Supplement 64: S75-S79
Mouridsen, H.T.; Palshof, T. 1984: Adjuvant systemic therapy in primary breast cancer Acta Chirurgica Scandinavica. Supplementum 519: 43-53
Mukhin, I.V.; Nikolenko, V.I. 2003: Experimental systemic enzyme therapy of gouty and primary glomerulonephritis Eksperimental'naia i Klinicheskaia Farmakologiia 66(4): 32-35
Takakuwa, T.; Endo, S.; Inada, K.; Kasai, T.; Yamada, Y.; Ogawa, M. 1997: Assessment of inflammatory cytokines, nitrate/nitrite, type Ii phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome Research Communications in Molecular Pathology and Pharmacology 98(1): 43-52
Uchikoshi, T.; Maeyama, S. 1995: Histopathological characteristics of alcoholic liver injury in cases with serum HCV markers Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 858-865
Serra, A.; Maiolino, L.; Cocuzza, S.; Di Luca, M.; Campione, G.; Licciardello, L.; Di Mauro, P. 2016: Assessment of oxidative stress markers and hearing thresholds in patients with obstructive sleep apnea-hypopnoea treated with cysteine and superoxide dismutase therapy Acta Bio-Medica: Atenei Parmensis 87(3): 253-258
Ricken, D.; Marsteller, H.J.; Baack, G. 1971: Immunosuppressive therapy of primary chronic polyarthritis and systemic lupus erythematodes disseminatus Die Medizinische Welt 39: 1501-1506
Gallo, M.; La Montagna, G.; Chianese, U.; Tirri, R.; Tirri, G. 1992: Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus Journal of Rheumatology 19(8): 1322-1323
O'Donoghue, J.Morgan.; Céspedes, Y.P.; Rockley, P.F.; Nigra, T.P. 2009: Skin biopsies to assess response to systemic corticosteroid therapy in early-stage TEN: case report and review of the literature Cutis 84(3): 138-40 161-2
Reuter, V.E. 1990: Pathology of bladder cancer: assessment of prognostic variables and response to therapy Seminars in Oncology 17(5): 524-532
Dank, M.; Zergenyi, E.; Domotori, Z.S.; Lahm, E.; Kulka, J. 2003: Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination Anticancer Research 23(3c): 2879-2880
Duan, S.; Luo, J.; Liu, F. 1999: Assessment of anticoagulant therapy in primary nephrotic syndrome Hunan Yi Ke da Xue Xue Bao 24(3): 301-303
Von Petrykowski, W.; Ketelsen, U.P.; Schmidt-Sommerfield, E.; Penn, D.; Sawicka, E.; Struck, E.; Lehnert, W.; Haap, K.; Strassburg, H.M. 1985: Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies Clinical Neuropathology 4(2): 63-71